EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use

Robert Kaufmann, Amber Harris Bozer, Amanda Kube Jotte, Keith Aqua

Medical Cannabis and Cannabinoids · 16.08.2023 · 6 (1) · 77-88

DOI: 10.1159/000531666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Cannabis and Cannabinoids, online erschienen am 16.08.2023. Verfasst von Robert Kaufmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Midwest Allergy Sinus Asthma PC, Springfield, IL, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Self-dosing of off-the-shelf cannabidiol (CBD) for a myriad of health conditions is common in the USA. These CBD products are often mislabeled, suggesting that much less or much more CBD is being consumed than indicated on the label. This study examined the relationship between long-term self-dosing of CBD and (a) indications and, when a verified concentration of CBD is being consumed, (b) the daily CBD dosage, (c) the impact on general health and symptoms, and (d) over-the-counter (OTC) and prescription (Rx) drug usage.

Methods

US adults 18–75 years of age who had used unverified CBD products for >1 month were recruited to participate in this decentralized, observational, IRB-approved study and provided a concentration-verified CBD product of their choice from 15 different vendors for 4 weeks. Prior to receiving product, they were queried on their primary reason for use (PRfU), primary symptom for use (PSfU), general health score (GHS), symptom score (SS), OTC and Rx drug use, and daily CBD dose. Individuals were queried daily on OTC and Rx drug use and CBD dose and weekly on SS and GHS prior to (pre-CBD) and after (post-CBD) ingestion of CBD on that day.

Results

The PRfU included chronic pain, mental health, general health and wellness, sleep disorders, the central nervous system, digestive health, and others, while the PSfU included anxiety, back and/or joint pain, sleep, inflammation, and others. The mean daily dose was normally distributed, with a mean, median, and range of 53.1, 40.8, 8–390 mg/day, respectively. For both GHS and SS, the post-CBD was significantly higher than the pre-CBD score for each category of PRfU. The GHS scores did not change over the study, but pre- and post-CBD SS improved over time, with pre-improving more than post-CBD SS. The percentage of individuals decreasing or completely stopping OTC drugs or Rx drugs over the 4 weeks was 31.2% and 19.2%, respectively, with those taking CBD for chronic pain, decreasing drug use the most. OTC and Rx drug usage decreased when the CBD dose was changed and when GHS and SS improved.

Conclusion

Pain, mental health (primarily anxiety/stress), and sleep are the most common reasons for CBD use. Self-administration of CBD reduced OTC and Rx drug usage at daily doses less than those reported in controlled studies. CBD self-administration significantly improves self-perception of general health and decreases symptom severity, and as these improve, fewer OTC and Rx drugs are used.

Schlagwörter

Stichwörter der Autor:innen

CannabidiolDosageDrug useHealthIndications

Autor:innen und Institutionen

  • Midwest Allergy Sinus Asthma PC, Springfield, IL, USA.
  • Department of Psychological Sciences, Tarleton State University, Stephenville, TX, USA.
  • Data Science Institute, University of Chicago, Chicago, IL, USA.
  • Syzygy Research Solutions, LLC, Wellington, FL, USA.

Zitieren

APA

Kaufmann, R., Bozer, A. H., Jotte, A. K., & Aqua, K. (2023). Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use. Medical Cannabis and Cannabinoids, 6(1), 77-88. https://doi.org/10.1159/000531666

Vancouver

Kaufmann R, Bozer AH, Jotte AK, Aqua K. Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use. Medical Cannabis and Cannabinoids. 2023;6(1):77-88. doi:10.1159/000531666

BibTeX
@article{Kaufmann2023,
  author = {Kaufmann, Robert and Bozer, Amber Harris and Jotte, Amanda Kube and Aqua, Keith},
  title = {Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use},
  journal = {Medical Cannabis and Cannabinoids},
  year = {2023},
  volume = {6},
  number = {1},
  pages = {77--88},
  doi = {10.1159/000531666}
}
Kostenlos starten →